Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
EJNMMI Research|April 18, 2020
Enhancing the therapeutic effects of in vitro targeted radionuclide therapy of 3D multicellular tumor spheroids using the novel stapled MDM2/X-p53 antagonist PM2Anja C L Mortensen, Eric Morin, Christopher J Brown, et al.Nuclear Medicine Communications|January 7, 2026
Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancerMaryam Oroujeni, Ram Kumar Selvaraju, Helena Persson, et al.Thyroid Research|October 2, 2025
CD44v6 expression in non-anaplastic thyroid carcinoma: characterization of candidates for targeted therapyAdam Stenman, Joachim N Nilsson, Vincenzo Condello, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2025
Preclinical Validation of [177Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human TrialsAnja C L Mortensen, Tabassom Mohajershojai, Amanda Gustafsson, et al.Pageof 1